Skip to main content

Table 1 Application of exosomes in the diagnosis of pancreatic diseases

From: Application of exosomes in the diagnosis and treatment of pancreatic diseases

Diseases

Source

Molecules

Mechanism

Years

Ref

AP

Plasma

S100A8 S100A9

Triggered NFκB activation, TNFα

2022

[33]

 

PAAF Plasma

miR

High pro-inflammatory activity on macrophages

2019

[34]

CP

Plasma

miR

High exosomal levels of miRNA-10b, miR-21, miR-30c, and miR-181a, and low levels of miR-let7a

2017

[22]

PaCa

Serum

Protein miR

Excellent sensitivity for PaCa versus CP

2015

[39]

 

PSC

miR

Stimulated the proliferation, migration, and expression of miRNAs for chemokine ligands

2017

[41]

Diabetes

Urine

Protein

AQP5 and AQP2 were used to classify the clinical stages of diabetic nephropathy

2017

[51]

 

Urine

miR

miR-145 may represent a novel biomarker for diabetic complications

2013

[52]

  1. AP acute pancreatitis, CP chronic pancreatitis, PaCa pancreatic cancer, PAAF pancreatitis-associated ascitic fluid, PSC pancreatic stellate cell